Jeremy N Ruskin, A John Camm, Christopher Dufton, Anderson C Woite-Silva, Ype Tuininga, Erik Badings, Jonas S S G De Jong, Thomas Oosterhof, Ismail Aksoy, Aaf F M Kuijper, Isabelle C Van Gelder, Vincent van Dijk, Dieter Nuyens, Dirk Schellings, Mark Young Lee, Peter R Kowey, Harry J G M Crijns, Jean Maupas, Luiz Belardinelli
BACKGROUND: INSTANT (INhalation of flecainide to convert recent-onset SympTomatic Atrial fibrillatioN to sinus rhyThm) was a multicenter, open-label, single-arm study of flecainide acetate oral inhalation solution (FlecIH) for acute conversion of recent-onset (≤48 hours) symptomatic atrial fibrillation (AF) to sinus rhythm. OBJECTIVES: This study investigated the efficacy and safety in 98 patients receiving a single dose of FlecIH delivered via oral inhalation...
March 26, 2024: JACC. Clinical Electrophysiology